Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Genelux Corporation
Genelux Corporation
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
AbbVie
Genmab
Imunon
AbbVie
AbbVie
Regeneron Pharmaceuticals
Merck Sharp & Dohme LLC
Corcept Therapeutics
Toray Industries, Inc
Hoffmann-La Roche
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Hoffmann-La Roche
ImmunoGen, Inc.
Hoffmann-La Roche
Genelux Corporation
Genentech, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.